Nsom challenge
AOB - Feels like a $10 stock in the making. Has numerous products on the "must buy" list in China. EPS last quarter brought the stock down into the buy range. Load up on dips near $5. Looking for a 30% gain on this one in the PSL timeframe, but could easily do more.
ASUR - my wildcard, and it definitely is that. Recently overthrew the board, and is now controlled by hedgies. It's also a low-price-listed-stock, and those have one-by-one been running in spurts. Let's shoot for .50, or 100% gain on this.
BSPM.OB - Chinese pharma that was a growth play, but due to recent dip in price is now growth + value. Microcaps are getting love right now, and BSPM will eventually join to the tune of 30-50% in the PSL timeframe.
CDBT.OB - Chinese biotech, but really they're on the feed side of the equation. Awfully cheap compared to growth and value. I won't freeze this for any gain under 75%.
WKBT.OB - Gaining VMC popularity, and rightly so. Seems to have a seller right now, but when the ship gets righted, 50+% is in the cards.
EXPECTED RETURN FOR PSL13 (assuming market cooperation): 40-60%
Solid DD combined with timeliness and conviction is a recipe for profits.
